Literature DB >> 17189668

Antimycin A induces apoptosis in As4.1 juxtaglomerular cells.

Woo-Hyun Park1, Yong-Whan Han, Sang-Wook Kim, Suhn-Hee Kim, Kyung-Woo Cho, Sung-Zoo Kim.   

Abstract

Antimycin A, an inhibitor of electron transport in mitochondria, has been used as reactive oxygen species (ROS) generator in the biological system. Here, we investigated the in vitro effect of antimycin A on apoptosis in As4.1 juxtaglomerular cells. Antimycin A efficiently induced apoptosis in As4.1 cells as evidenced by flow cytometric detection of sub-G(1) DNA content, annexin V binding assay and DAPI staining. This apoptotic process was accompanied by loss of mitochondrial transmembrane potential (DeltaPsi(m)), Bcl-2 decrease, caspase-3 activation and PARP cleavage. All of caspase inhibitors tested in this experiment failed to rescue As4.1 cells from antimycin A-induced cell death at the time of 48 h in view of sub-G(1) cells and annexin V positive staining cells. However, with regard to the mitochondrial membrane potential (DeltaPsi(m)), pan caspase inhibitor (Z-VAD-FMK) and caspase-3 inhibitor (Z-DEVD-FMK) at the concentration of 25 microM noticeably decreased the loss of mitochondrial membrane potential (DeltaPsi(m)) in antimycin A-treated cells. Taken together, we have demonstrated that antimycin A as an inhibitor of electron transport in mitochondria potently induces apoptosis in As4.1 juxtaglomerular cells.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17189668     DOI: 10.1016/j.canlet.2006.11.002

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  6 in total

1.  Upregulated autophagy protects cardiomyocytes from oxidative stress-induced toxicity.

Authors:  Debapriya Dutta; Jinze Xu; Jae-Sung Kim; William A Dunn; Christiaan Leeuwenburgh
Journal:  Autophagy       Date:  2013-01-08       Impact factor: 16.016

2.  Targeting glycolysis in leukemia: a novel inhibitor 3-BrOP in combination with rapamycin.

Authors:  Lauren J Akers; Wendy Fang; Alejandro G Levy; Anna R Franklin; Peng Huang; Patrick A Zweidler-McKay
Journal:  Leuk Res       Date:  2011-02-12       Impact factor: 3.156

3.  The effects of MAPK inhibitors on antimycin A-treated Calu-6 lung cancer cells in relation to cell growth, reactive oxygen species, and glutathione.

Authors:  Yong Hwan Han; Woo Hyun Park
Journal:  Mol Cell Biochem       Date:  2010-01       Impact factor: 3.396

4.  Neuroprotective effect of leukemia inhibitory factor on antimycin A-induced oxidative injury in differentiated PC12 cells.

Authors:  Yangguang Han; Jing Xu; Zhigui Li; Zhuo Yang
Journal:  J Mol Neurosci       Date:  2013-05-01       Impact factor: 3.444

Review 5.  Emerging metabolic targets in the therapy of hematological malignancies.

Authors:  Zaira Leni; Geetha Parakkal; Alexandre Arcaro
Journal:  Biomed Res Int       Date:  2013-08-18       Impact factor: 3.411

6.  Chemical, biological and in silico assessment of Ocimum viride essential oil.

Authors:  Madhulika Bhagat; Monica Sangral; Ajay Kumar; Rafiq A Rather; Khushboo Arya
Journal:  Heliyon       Date:  2020-06-23
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.